Requires manufacturers of synthetic braiding hair, weaves, and extensions to disclose all ingredients used in the manufacturing of such products

2025 Regular Session Introduced by Alicia Hyndman

Requires manufacturers of synthetic braiding hair, weaves, and extensions to disclose all ingredients, boosting consumer transparency about product composition.

REFERRED TO CONSUMER AFFAIRS AND PROTECTION

Summary of Bill A 7001

What the bill would do

Requires manufacturers of synthetic braiding hair, weaves, and extensions to disclose all ingredients used in the manufacturing of these products.

The intended effect is to increase transparency for consumers regarding the composition of synthetic hair products.

Status and sponsorship

Status: Referred to the Consumer Affairs and Protection committee.

Introduced: March 18, 2025.

Sponsor (primary): Alicia Hyndman.

Key provisions (as described in the information provided)

Disclosure obligation: Manufacturers of synthetic braiding hair, weaves, and extensions must disclose all ingredients used in manufacturing these products.

Scope of products: Applies specifically to synthetic braiding hair, weaves, and extensions.

Disclosure mechanism: The available information does not specify how disclosures must be provided (e.g., product labeling, packaging inserts, online database, or another method). The bill text would define the method if enacted.

Who is affected

Primary: Manufacturers of synthetic braiding hair, weaves, and extensions.

Related parties: Potentially distributors, retailers, and importers who handle these products, depending on how the disclosure requirement would be implemented in practice.

Potential impacts and considerations

Consumer transparency: Could improve consumer awareness of product composition, with potential benefits for those with allergies or sensitivities.

Compliance costs: Manufacturers may incur costs to compile, verify, and disclose all ingredients; small manufacturers could face greater relative burden.

Trade secrets and competitive concerns: Disclosures could raise questions about protecting proprietary formulations; the bill’s text would need to address any balancing of public safety with business confidentiality.

Regulatory process: With the bill currently referred to committee, further actions (amendments, hearings, and potential passage) would determine final scope and timelines.

Timeline and next steps

Currently in committee (Consumer Affairs and Protection) as of March 18, 2025.

No further actions or enacted provisions are listed in the information provided. If advanced, the bill would move to subsequent committee considerations and, potentially, floor votes, depending on legislative calendaring.

Additional notes

The provided details do not include definitions of “ingredients,” specific disclosure formats, penalties for noncompliance, effective dates, or enforcement mechanisms. The exact text of the bill would clarify these elements.